Skip to main content

Together we are beating cancer

Donate now

For Researchers | Analysis

Read analysis articles in our For Researchers section
Showing 12 out of 62 results
Big data

Spoiler-alert… no. At least not yet. But it is revolutionising the field in incredible ways. Bissan Al-Lazikani gets into where we are with AI and drug discovery... Spoiler-alert… no. At least not yet. But it is revolutionising the field in incredible ways. Bissan Al-Lazikani gets into where we are with AI and drug discovery...

by Cancer Research UK | Analysis | 21 April 2026

21 April 2026

This entry is part 3 of 3 in the series Data science
%postcontent%
Academic publishing

The open access movement was bold and promising, but ultimately disappointing. Now is the time to stop and call for a new way to make publishing work… The open access movement was bold and promising, but ultimately disappointing. Now is the time to stop and call for a new way to make publishing work…

by Cancer Research UK | Analysis | 1 April 2026

1 April 2026

This entry is part 2 of 2 in the series Minding the gap
%postcontent%
Big data

We are awash with data – but how do cancer researchers make the most of it at the scale and pace needed whilst also keeping the trust of patients? We are awash with data – but how do cancer researchers make the most of it at the scale and pace needed whilst also keeping the trust of patients?

by Cancer Research UK | Analysis | 24 February 2026

24 February 2026

This entry is part 2 of 3 in the series Data science
%postcontent%
Careers

Good leadership is vital for successful science – so how, exactly, do you get good at it? Ally Walters talks us through it... Good leadership is vital for successful science – so how, exactly, do you get good at it? Ally Walters talks us through it...

by Cancer Research UK | Analysis | 11 February 2026

11 February 2026

This entry is part 8 of 8 in the series Research Careers
%postcontent%
Minding the gap

Tim Bodicoat ponders the thawing of the biotech winter and asks if the market can ever tell you if it’s the right time to launch a start-up… Tim Bodicoat ponders the thawing of the biotech winter and asks if the market can ever tell you if it’s the right time to launch a start-up…

by Tim Bodicoat | Analysis | 3 February 2026

3 February 2026

This entry is part 1 of 2 in the series Minding the gap
%postcontent%
Up and running - how to speed up clinical trials

The UK is ideally suited for early phase oncology trials, so is it possible to speed up set-up time? Sharan Sandhu tells us how we could... The UK is ideally suited for early phase oncology trials, so is it possible to speed up set-up time? Sharan Sandhu tells us how we could...

by Phil Prime | Analysis | 15 December 2025

15 December 2025

Data science column

LLMs are impressive yet they also pose a threat to science. The first column in our new series on data science gets into the dichotomy... LLMs are impressive yet they also pose a threat to science. The first column in our new series on data science gets into the dichotomy...

by Cancer Research UK | Analysis | 11 November 2025

11 November 2025

This entry is part 1 of 3 in the series Data science
%postcontent%
Careers

Clinical academics hold a vital place in the cancer research landscape; so why is it proving so hard to retain them, and what can we do about it? Clinical academics hold a vital place in the cancer research landscape; so why is it proving so hard to retain them, and what can we do about it?

by Cancer Research UK | Analysis | 14 October 2025

14 October 2025

This entry is part 7 of 8 in the series Research Careers
%postcontent%
ageing

The transition from normal to pre-cancerous tissue remains underexplored. Ageing research, by contrast, has long studied normal tissue decline... The transition from normal to pre-cancerous tissue remains underexplored. Ageing research, by contrast, has long studied normal tissue decline...

by Cancer Research UK | Analysis | 27 August 2025

27 August 2025